New Delhi: CureMeAbroad has secured $600,000 in pre-seed funding from a group of angel investors.
Funding Details And Investors
Pune-based medical tourism startup CureMeAbroad raised $600,000 in its pre-seed funding round, drawing participation from investors including Roman Saini, co-founder of Unacademy, along with Himanshu Ratnoo, former CEO of Cars24 India, Kunal Gupta of EMotorad, Devaiah Bopanna of Moonshot, Vikrant Potnis of IAVC, and AIRA Buildon. The funding marks an early milestone for the startup, which was founded in June 2025 by Aditya Oza and Mikhail Bohra.
Platform Focus And Market Opportunity
CureMeAbroad operates in the medical tourism segment, connecting international patients with hospitals and specialists across destinations such as India, Turkey, Thailand, and Mexico. The company states that its platform currently features around 6,000 hospital listings and works with about 380 partner hospitals. The startup is building an AI-based discovery system aimed at helping patients compare treatment options, estimate costs, and identify suitable healthcare providers before travelling abroad.
Growth Plans And Use Of Funds
The company plans to deploy the fresh capital toward strengthening its technology stack, including expanding its AI-driven cost estimation tools and clinical matching systems. It also intends to hire talent across product development, clinical operations, and international partnerships. In addition, CureMeAbroad aims to expand its presence in selected overseas markets, with an initial focus on the Gulf Cooperation Council (GCC), the UK, and parts of Africa.
Industry Context And Early Performance
Medical tourism continues to attract investment as patients increasingly seek treatment outside their home countries due to cost and availability factors. CureMeAbroad reported reaching an annual run rate of about $3.5 million within its first two quarters of operations, reflecting early traction in a market projected to grow significantly over the next decade.
